RE:RE:Zenabis and NamasteThese are both highly undervalued companies at current prices with zenabis having production strengths which can be compared to the top 3-4 cannabis cos in Canada and competitive average price/gms, great contracts nationally and internationally. The debt is very well manageable for zenabis with revenue improving substantially, results this quarter will speak for themselves. Keep a look out for 50-80% ROI at current prices by aug 15th.
namaste hit rock bottom last week for this quarter and there is upside from here, historical price jumps for namaste speak for the themselves, cannabis 2.0 and vapes will add numbers, their strength is not only B2C but very soon B2B will be the crown